Literature DB >> 1945408

cyl encodes a putative cytoplasmic tyrosine kinase lacking the conserved tyrosine autophosphorylation site (Y416src).

J Partanen1, E Armstrong, M Bergman, T P Mäkelä, H Hirvonen, K Huebner, K Alitalo.   

Abstract

We have isolated a cDNA encoding a novel tyrosine kinase family member, named cyl (consensus tyrosine-lacking kinase), from the K562 human leukemia cell line. The deduced cyl protein lacks signal and transmembrane sequences but contains features of known cytoplasmic tyrosine kinases, including amino-terminal SH3 and SH2 domains. However, having very short amino and carboxy termini, cyl does not seem to belong to any of the previously characterized subfamilies of cytoplasmic tyrosine kinases. Furthermore, cyl lacks the highly conserved tyrosine autophosphorylation site (Y416src) in the tyrosine kinase catalytic domain. The cyl gene is located on human chromosome 15. It is expressed ubiquitously as two independently regulated mRNA species of 2.6 and 3.4 kb in human leukemia cell lines and fetal tissues.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945408

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

Review 1.  Positive and negative regulation of T-cell activation through kinases and phosphatases.

Authors:  Tomas Mustelin; Kjetil Taskén
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

Review 3.  Role of tyrosine kinases in lymphocyte activation: targets for drug intervention.

Authors:  J H Hanke; B A Pollok; P S Changelian
Journal:  Inflamm Res       Date:  1995-09       Impact factor: 4.575

4.  Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.

Authors:  Souad Rahmouni; Torkel Vang; Andres Alonso; Scott Williams; Marianne van Stipdonk; Chiara Soncini; Michel Moutschen; Stephen P Schoenberger; Tomas Mustelin
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

5.  Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.

Authors:  S M Murphy; M Bergman; D O Morgan
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

6.  Myristylation is required for Tyr-527 dephosphorylation and activation of pp60c-src in mitosis.

Authors:  S Bagrodia; S J Taylor; D Shalloway
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

7.  The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src.

Authors:  K Neet; T Hunter
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

8.  Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.

Authors:  E Buchdunger; J Zimmermann; H Mett; T Meyer; M Müller; U Regenass; N B Lydon
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Ntk: a Csk-related protein-tyrosine kinase expressed in brain and T lymphocytes.

Authors:  L M Chow; C Jarvis; Q Hu; S H Nye; F G Gervais; A Veillette; L A Matis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase.

Authors:  M Autero; J Saharinen; T Pessa-Morikawa; M Soula-Rothhut; C Oetken; M Gassmann; M Bergman; K Alitalo; P Burn; C G Gahmberg
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.